Safety, Tolerability, and Pharmacokinetics of CSX-1004

Clinical trial NCT06005402 · COMPLETED

Trial details

NCT number: NCT06005402
Sponsor: Cessation Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid Overdose Opioid Use Disorder

Start date: 2023-08-01
Primary completion: 2024-05-28
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.